Online inquiry

IVTScrip™ mRNA-Human ALDH1A1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK19594MR)

This product GTTS-WK19594MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ALDH1A1 protein. This product can be used in Cancer stem cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_000689.5
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 216
UniProt ID P00352
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ALDH1A1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK19594MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK26338MR IVTScrip™ mRNA-Human ATAD3A, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ATAD3A
GTTS-WK15458MR IVTScrip™ mRNA-Human AMPD2, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA AMPD2
GTTS-WK10310MR IVTScrip™ mRNA-Human ACADVL, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ACADVL
GTTS-WK5104MR IVTScrip™ mRNA-Human VASA, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA VASA
GTTS-WK18692MR IVTScrip™ mRNA-Human Aldehyde Dehydrogenase 1-A1, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA Aldehyde Dehydrogenase 1-A1
GTTS-WK16925MR IVTScrip™ mRNA-Human ALKBH4, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ALKBH4
GTTS-WK12067MR IVTScrip™ mRNA-Human ABHD17B, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ABHD17B
GTTS-WK27839MR IVTScrip™ mRNA-Human ATAD3B, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ATAD3B
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW